Evidence-Based Diagnosis and Treatment of Treatment-Resistant Depression

For European Depression Day, the EPA is pleased to announce the webinar “Evidence-Based Diagnosis and Treatment of Treatment-Resistant Depression – Update and Preview”, taking place on Monday, 27 October 2025, from 16:00 to 18:00 CET. This webinar is organised by the EPA Section on Psychopharmacology.

Welcome to the third edition in the EPA Webinar Series 2025. 
This 90-minute webinar will take place on Monday, 27 October, from 16:00 to 18:00 CET.

Major depressive disorder (MDD) affects over 300 million people worldwide. The so-called treatment-resistant depression (TRD) represents a subgroup of this condition, but inconsistent international definitions make it difficult to estimate its exact prevalence. 

This webinar will enable the attendees to gain knowledge on the evidence-based diagnostics and treatment of the so-called TRD. Besides the introduction of the clinical phenotype of TRD, a detailed information will be provided for the approved as well as experimental pharmacological and non-pharmacological treatment strategies, as well as their best possibly effective and safe use in TRD according to the recommended therapeutic algorithms.

For any question, please contact Simone De Ioanna (simone.deioanna@europsy.net) in advance of the webinar.

You are welcome to share this free & open webinar with your colleagues, students, and peers!